SCHEMBL23097242

SCHEMBL23097242

c1ccc2oc(-c3ccc4c(c3)c3ccccc3n4-c3ccc(-c4ccc(-c5ccc(-n6c7ccccc7c7cc(-c8nc9ccccc9o8)ccc76)cc5)cc4)cc3)nc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 10/20 0.49
▸ HPGD P15428 10/20 0.49
▸ ALDH1A1 P00352 10/20 0.49
▸ NPC1 O15118 9/20 0.49
▸ RAB9A P51151 7/20 0.49
▸ SMN1; SMN2 Q16637 7/20 0.49
▸ HSD17B10 Q99714 5/20 0.49
▸ MAPT P10636 4/20 0.49
▸ HCRTR1 O43613 2/20 0.49
▸ USP2 O75604 2/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.49
▸ TSHR P16473 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ CASP3 P42574 1/20 0.49
▸ SENP8 Q96LD8 1/20 0.49
▸ SENP7 Q9BQF6 1/20 0.49
▸ SENP6 Q9GZR1 1/20 0.49
▸ MEN1 O00255 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ ATM Q13315 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23097254 1.00 KDM4E (0.49) KDM4EHPGDALDH1A1NPC1RAB9A
SCHEMBL22747045 1.00 KDM4E (0.49) KDM4EHPGDALDH1A1NPC1RAB9A
SCHEMBL23108755 0.99 KDM4E (0.50) KDM4EHPGDALDH1A1NPC1RAB9A
SCHEMBL22746704 0.99 KDM4E (0.50) KDM4EHPGDALDH1A1NPC1RAB9A
SCHEMBL10065318 0.97 NPC1 (0.47) KDM4EHPGDALDH1A1NPC1RAB9A
SCHEMBL22747032 0.96 NPC1 (0.46) KDM4EHPGDALDH1A1NPC1RAB9A
SCHEMBL27282344 0.96 NPC1 (0.46) KDM4EHPGDALDH1A1NPC1RAB9A
SCHEMBL23108443 0.96 NPC1 (0.50) KDM4EHPGDALDH1A1NPC1RAB9A
SCHEMBL23108756 0.96 NPC1 (0.50) KDM4EHPGDALDH1A1NPC1RAB9A
SCHEMBL23108467 0.95 KDM4E (0.47) KDM4EHPGDALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3792259-B1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME CHANGCHUN HYPERIONS TECH CO LTD (CN) 2023-11-29 — — EP disclosed
US-20210078989-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME CHANGCHUN HYPERIONS TECHNOLOGY CO., LTD (CN) 2021-03-18 — — US disclosed
EP-3792259-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME Changchun Hyperions Technology Co., Ltd. (CN) 2021-03-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078989-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME SOX18, TYR, L1CAM KDM4E 148/4885HPGD 3469/4885ALDH1A1 1610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback